Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/cid/cix067 http://scihub22266oqcxt.onion/10.1093/cid/cix067 C5849092!5849092 !28362950     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28362950 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28362950 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Clin+Infect+Dis 2017 ; 64 (7 ): 823-828 Nephropedia Template TP {{tp|p=28362950 |t=2017. Crisis in Infectious Diseases: 2 Decades Later |pdf=|usr=}}{{28362950 }} gab.com Text Crisis in Infectious Diseases: 2 Decades Later JO: Clin Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=28362950 #FOAvip The development of nontoxic broad-spectrum antimicrobial drugs in the mid-20th century led to a culture of empiricism, underdevelopment of diagnostics, neglect of immunotherapy, and selection for drug resistance, which together created the conditions that underlie the current crisis. In 1996 an article in this journal predicted a crisis in infectious diseases, which subsequently unfolded with a paucity of new drugs, increases in antimicrobial resistance, and underdevelopment in both immunotherapy and diagnostics. This article argues that the root cause of the current-day problems lies in the enormous success of the mid-20th century antibiotic revolution. The availability of low-toxicity broad-spectrum drugs fostered a culture of empiricism and widespread use, which in turn stunted the development of both the specialty and rapid diagnostics while promoting increases in resistance. Two decades later, there are promising signs that widespread recognition of these problems is leading to fundamental changes in the approach to the therapy of infectious diseases. Ultimately, a concerted effort to simultaneously develop pathogen-specific drugs, immunotherapy, and improved diagnostics could provide a qualitatively new platform for confronting the challenge of infectious diseases, which now also includes host dysbiosis. Twit Text FOAVip Crisis in Infectious Diseases: 2 Decades Later ????Clin Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=28362950 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28362950 #FOAvip English Wikipedia <ref>{{Cite pmid|28362950 }}</ref> Crisis in Infectious Diseases: 2 Decades Later #MMPMID28362950 Casadevall A Clin Infect Dis 2017[Apr]; 64 (7 ): 823-828 PMID28362950 show ga The development of nontoxic broad-spectrum antimicrobial drugs in the mid-20th century led to a culture of empiricism, underdevelopment of diagnostics, neglect of immunotherapy, and selection for drug resistance, which together created the conditions that underlie the current crisis. In 1996 an article in this journal predicted a crisis in infectious diseases, which subsequently unfolded with a paucity of new drugs, increases in antimicrobial resistance, and underdevelopment in both immunotherapy and diagnostics. This article argues that the root cause of the current-day problems lies in the enormous success of the mid-20th century antibiotic revolution. The availability of low-toxicity broad-spectrum drugs fostered a culture of empiricism and widespread use, which in turn stunted the development of both the specialty and rapid diagnostics while promoting increases in resistance. Two decades later, there are promising signs that widespread recognition of these problems is leading to fundamental changes in the approach to the therapy of infectious diseases. Ultimately, a concerted effort to simultaneously develop pathogen-specific drugs, immunotherapy, and improved diagnostics could provide a qualitatively new platform for confronting the challenge of infectious diseases, which now also includes host dysbiosis. |*Drug Resistance, Microbial [MESH] |*Global Health [MESH] |Anti-Infective Agents/isolation & purification/*pharmacology/*therapeutic use [MESH] |Communicable Diseases, Emerging/drug therapy/epidemiology [MESH] |Communicable Diseases/*drug therapy/*epidemiology [MESH] |Humans [MESH]Crisis in Infectious Diseases: 2 Decades Later (epmc).pdf DeepDyve Pubget Overpricing